Antipsychotic depots/LAIs
| Antipsychotic depots /Long acting injections (LAIs) | Preparations | Comments |
| See guidance on IM Administration of oil-based Depot and other Long-Acting Antipsychotic Injections | ||
| Aripiprazole | 400mg injection |
See Appendix 4 Guidance on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults Feb 2023 |
| Flupentixol decanoate | 20mg/ml, 40mg/2ml, 50mg/0.5ml, 100mg/1ml, 200mg/ml injection | |
| Haloperidol decanoate | 50mg/ml, 100mg/ml injection | Baseline ECG is recommended. See DTC recommendation on haloperidol and ECG monitoring |
| Paliperidone palmitate 1-monthly(Xeplion®) | 50mg, 75mg, 100mg, 150mg pre-filled syringes |
Tablets NOT APPROVED. See Appendix 2 Guidance on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults Feb 2023 |
| Paliperidone palmitate 3-monthly (Trevicta®) | 175mg, 263mg, 350mg, 525mg pre-filled syringes |
Named patient request ONLY See Appendix 3 Guidance on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults Feb 2023 |
| Zuclopenthixol deconoate (Clopixol®) | 200mg/ml, 500mg/ml injection | |